The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Singh Juliet since year 2005.
The trader's CIK number is 1421383.
At the time of this reporting, Singh Juliet is the CEO, Director and Pr of Transdel Pharmaceuticals Inc .
(stock ticker symbol TDLP.OB).
See this page for all insider trading activities at Transdel Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2008-09-29||TDLP.OB||Transdel Pharmaceuticals Inc||Buy||500||1.40||700|
|2008-09-26||TDLP.OB||Transdel Pharmaceuticals Inc||Buy||500||1.40||700|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Singh Juliet (CEO, Director and Pr of Transdel Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.